From Corporate Intelligence:
- Getty Images
You might think Nestlé’s supply-chain effort is limited to edibles
like chocolate chips for its Toll House cookies, but there’s so much
more going on beneath the surface at the Swiss food producer. From the WSJ:
Under the deal, Nestlé will obtain brain and liver cells from Cellular Dynamics International Inc.ICEL +1.05%
and study how nutrients found in foods affect these human cells,
according to Emmanuel Baetge, director of the Nestlé Institute of Health
Sciences, a research arm of the Swiss company. Nestlé aims to use the
insights to develop nutritionally enhanced drinks, smoothies and other
products that it can market as having medical benefits.
Cellular Dynamics supplies its cells to most of the top
pharmaceutical players, but the Nestlé deal is the first time it is
doing business with a food company. The plan, according to Emmanuel
Baetge, director of Nestlé’s research arm, is to ”to take advantage of
the space between food and pharmaceuticals.”...MORE
